These trials completed more than 12 months ago and should have reported results.
These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.
These trials have problematic data on the registry. Details why »
|Status||Trial ID||Title||Completion date||Category|
|Reported results||2004-003236-59||Double blind placebo controlled clinical investigation into the efficacy and tolerability of inhaled treprostinil in patients with severe pulmonary arterial hypertension.||2011-07-20||due-trials|
|Completed, but no date, and reported results||2008-003290-41||A Multi-center, open-label, multiple dose, dose finding study exploring the safety and tolerability of Beraprost Sodium Modified Release in PAH patients||bad-data|
|Listed as ongoing, but also has a completion date and reported results||2009-014246-29||A 12-week, double-blind, international, multicenter, dose-response study of the safety and efficacy of Beraprost Sodium Modified Release (BPS-MR) in patients with pulmonary arterial hypertension (PAH)||2011-12-12||bad-data|
|Listed as ongoing, but also has a completion date and reported results||2009-014453-32||An open-label extension of BPS-MR-PAH-203 in pulmonary arterial hypertension (PAH) patients||2013-11-26||bad-data|